Last reviewed · How we verify

NCT05496621

Validity and Reliability of Turkish Version of Keele STarT MSK Tool

Completed NA Last updated 11 August 2022
What this trial tests

NA trial testing Questionnaire in Musculoskeletal Diseases in 30 participants. Completed in 1 November 2019.

Timeline
1 February 2019
Primary endpoint
1 May 2019
1 November 2019

Quick facts

Lead sponsorIstinye University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment30
Start date1 February 2019
Primary completion1 May 2019
Estimated completion1 November 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istinye University

Who can join

Adults 18 to 85, any sex, with Musculoskeletal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the usability of the Turkish version of the Keel Start Tool as a valid and reliable method in groups with 5 different types of musculoskeletal pain (knee, neck, shoulder, back, multiple painful areas). When the literature is examined, Turkish validity has not been made in this area.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Questionnaire

Trials testing the same drug.

Other recruiting trials for Musculoskeletal Diseases

Currently open trials in the same condition.

Other Istinye University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05496621.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing